申请人:NIPPON SHINYAKU COMPANY, LIMITED
公开号:EP0249043A2
公开(公告)日:1987-12-16
Quinolinecarboxylic acid derivatives represented by the following general formula (I) and physiologically-acceptable salts thereof.
wherein R' is hydrogen, alkyl, or substituted or unsubstituted phenyl; R2 is hydrogen, alkyl, alkoxy, hydroxy, halogen, nitro or substituted or unsubstituted amino; R3 is hydrogen or optionally-substituted alkyl; R4 and R5 are same or different and are alkyl or hydroxyalkyl or R4 and R5 may be combined and may form a cyclic amino together with the adjacent nitrogen atom and said cyclic amino may also be substituted and may further contain nitrogen, oxygen or sulfur as heteroatoms therein; and X is halogen, have been found to be very effective antibacterial therapeutic agents for systemic and local infectious diseases caused by P. aeruginosa and Gram-positive and negative bacteria.
由以下通式(I)代表的喹啉羧酸衍生物及其生理上可接受的盐类。
其中 R' 是氢、烷基或取代或未取代的苯基;R2 是氢、烷基、烷氧基、羟基、卤素、硝基或取代或未取代的氨基;R3 是氢或任选取代的烷基;R4 和 R5 相同或不同,并且是烷基或羟基烷基,或者 R4 和 R5 可以结合,并且可以与相邻的氮原子一起形成环状氨基,所述环状氨基也可以被取代,并且可以进一步含有氮、氧或硫作为杂原子;以及 X 是卤素。铜绿假单胞菌以及革兰氏阳性和阴性细菌引起的全身和局部感染性疾病的非常有效的抗菌治疗剂。